Fierce Healthcare Fundraising Tracker —Zeal Capital Partners collects $82M; R1 secures investment from Khosla Ventures

At Fierce Healthcare, we keep track of all the venture capital being funneled into the health tech and digital health industries.

Our fundraising tracker provides updated coverage of noteworthy digital health and health tech funding rounds, though we'll still profile exciting new companies and larger rounds that catch our eye in depth.

Do you have fundraising news to share? Email Senior Editor Heather Landi at [email protected].


Zeal Capital Partners collects $82M for Fund II

Washington, D.C.-based venture capital firm Zeal Capital Partners closed its second fund, Zeal Fund II, raising $82 million. This more than triples Zeal’s total assets under management to $186 million across three funds, according to the firm.

Fund II will focus on financial technology, healthcare, and the future of learning and work, executives said in a press release.

The close of Zeal Fund II marks a significant expansion of the firm’s institutional investor base, the company said. Zeal's limited partners now include Citi Impact Fund, M&T Bank, MassMutual, Wells Fargo, Zaffre Investments and Spelman College. Nearly 80% of Zeal’s Fund I investors—including Capricorn Investment Group and Hampton University—continued their investment partnership in Zeal Fund II.

Zeal Fund II will invest in approximately 25 early-stage companies over a four-year investment period, with a strategy designed to lead or co-lead seed-stage financings. The mandate will target initial check sizes between $1 million and $2.3 million, with the option to serve on the board of directors when appropriate to support the growth of portfolio companies, the company said. And, Zeal Fund II will reserve 50% of its committed capital for follow-on investments, ensuring the firm can continue backing its highest-performing companies through subsequent stages of scale.

The firm's healthcare investments to date include women's behavioral health services provider Seven Starling, Primary Health, Auxa Health, Aster and virtual autoimmune care provider Viu Health.


Prepared preps for U.S. expansion fueled by $80M series C round

Startup Prepared built an artificial intelligence-powered solution for emergency responders. The company raised $80 million in series C funding to boost nationwide adoption of its technology.

General Catalyst led the funding round, with participation from returning investors Andreessen Horowitz (a16z) and First Round Capital. Joining General Catalyst as a new investor, Radical Ventures, a fund focused on investing in transformative AI, also participated in the round. 

This round of funding brings Prepared’s total investments to over $130 million.

Prepared’s platform equips public health agencies with AI-powered tech. 911 professionals are amongst the most technologically underserved civil servants in the United States, according to the company. When high call volumes collide with understaffing and inadequate tools, on calls where every second matters, lives are placed in harm’s way. Prepared's platform is designed to ease the burden of these challenges by acting as an assistant, empowering each telecommunicator with easy-to-use, seamless solutions during critical emergencies. 

The company launched its first emergency response focused product in the fall of 2021 and Prepared's integrated AI solution is now used by more than 1,000 in 49 states. The company's clients include Las Vegas Metro PD, the Metro Nashville Department of Emergency Communications, Hillsborough County Sheriff’s Department, Delaware County Emergency Services, and El Paso 911. 

The funding round follows Prepared's launch of the first end-to-end assistive AI platform for emergency response in December 2024. Automated Non-Emergency Triage, a dynamic AI voice assistant currently deployed in multiple agencies, significantly reduces the burden of high-volume non-emergency calls on emergency call-takers. 


R1 RCM receives backing from Khosla Ventures

R1 RCM  picked up an undisclosed investment from Khosla Ventures to accelerate its expansion into artificial-intelligence-powered healthcare revenue cycle technology and build on its strategy to apply agentic AI to the RCM space.

The investment follows the launch of R37, R1’s enterprise-grade AI lab developed in partnership with Palantir that leverages agentic AI applications.

Administrative costs account for over 40% of hospital expenses, and more than $160 billion is spent annually on revenue cycle operations alone. R1 says its R37 AI lab addresses this challenge head-on, delivering agentic AI solutions built on R1’s proprietary data set that automate labor-intensive workflows such as coding, billing and denials management.

R1 works with 94 of the top 100 U.S. health systems and manages a vast repository of proprietary RCM data, including more than 180 million annual payer transactions, 1.2 billion annual workflow actions and 20,000 proprietary automation algorithms.

“Following the milestone launch of R37 this year, having Khosla Ventures as an investor is both a validation and a catalyst for the opportunity we see ahead as we bring our proprietary, agentic AI solution to the healthcare ecosystem,” said Joe Flanagan, CEO of R1. 

In August, R1 RCM was taken private in a $8.9 billion deal with TowerBrook Capital Partners and Clayton, Dubilier & Rice.


Akido Labs snags $60M to build out ScopeAI

Oak HC/FT backed artificial intelligence and care delivery company Akido Labs in its $60 million series B funding round. Greco, SNR and existing investors Y Combinator, Future Communities Capital, Jeff Dean (chief scientist, Google DeepMind and Google Research) and the Comprehensive Blood & Cancer Center also participated in the round. 

Akido was founded in 2015 with the goal of reimagining healthcare for historically vulnerable communities by leveraging AI and machine learning. In 2022, Akido launched Akido Care, a medical network that today includes nearly 100 clinics, offering primary and specialty care across 26 sub-specialties.  

The company developed ScopeAI, a clinical AI system available to providers that aims to increase clinical capacity. ScopeAI is an AI-driven clinical co-pilot that assists medical assistants and physicians during patient visits. 

The U.S. population requires over 3 billion doctor visits per year, yet only 825 million are currently available. The result is longer waits, especially for specialists, rushed appointments and rising rates of preventable disease, the company says. 

Akido embeds medical intelligence directly into the clinical workflow to bring scale, efficiency and consistency to the front lines of care.

The company built ScopeAI using its proprietary data set of over 10 million patient case studies and reinforcement-loop-human-feedback environment to launch ScopeAI.

In a ScopeAI visit, a trained Medical Assistant meets with a patient, guided by intelligent prompts from ScopeAI throughout the encounter. ScopeAI uses clinical reasoning to actively listen, adapt in real time and build a comprehensive understanding of the patient’s condition. Its scribing and auditory capabilities allow for dynamic conversation while simultaneously generating a full clinical report, including a preliminary diagnosis, treatment plan and justification log for each decision it makes. An Akido provider can oversee a team of Medical Assistants conducting ScopeAI visits, increasing access to care while enabling the provider to focus on higher-acuity or more complex cases.

The series B funding will be used to expand the reach of ScopeAI throughout its Akido Care medical network of 240 providers across 26 specialties, the company said. It will also help support Akido’s entrance into new markets like the recently announced healthcare program in New York City that is designed to address specific chronic diseases for professional ride-share and for-hire drivers.

“We built ScopeAI to tackle the single biggest challenge facing healthcare systems worldwide: the physician shortage. With demand for care far exceeding supply, AI is the key to addressing the global doctor deficit, empowering healthcare providers, and ensuring patients receive the timely, high-quality care they deserve, regardless of financial means or geography,” Prashant Samant, co-founder and CEO of Akido, said in a statement. 


Sprinter Health scores $55M to grow at-home healthcare services

On-demand mobile health company Sprinter Health secured $55 million in series B funding to expand its services and scale its technologies.

The company, founded in 2021, pairs virtual and in-home care. Sprint Health has now raised more than $125 million.

General Catalyst led the series B round. Andreessen Horowitz (a16z) Bio + Health and other existing investors including the Regents of the University of California, Google Ventures and Accel also backed the round. 

Sprinter Health specializes in engaging hard to reach populations, utilizing a technology-first approach paired with in-person clinical staff to increase access to care. The company says it's redefining home health initiatives for health plans by combining an artificial-intelligence-powered logistics platform with a full-stack clinical model: in-home staff trained as medical assistants and community health workers supported by virtual nurse practitioners and care teams.

The company's staff, called "sprinters," visit patients in their homes homes to provide lab draws, vitals checks like blood pressure and heart rate and colorectal cancer screenings, among other services.

Sprinter Health says its “human touch plus tech” model engages hard-to-reach patients and routes them back into longitudinal care, not just one-off transactions.

The company has completed nearly 100,000 in-home visits, expanded from five to 18 states in the last year, and aims to reach 22 states by the end of summer. Its platform handles everything from chronic care assessments to lab draws, diabetic eye exams and lead screenings delivered by staff recruited from patients’ own communities.


PhaseV lands $50M series A

PhaseV, an artificial-intelligence-enabled clinical development company, secured $50 million in series A funding. The round was co-led by Accel and Insight Partners, and existing investors Viola Ventures, EXOR and LionBird also backed the round.

The startup is developing advanced AI and machine learning solutions to optimize clinical development. Biopharma sponsors and clinical research organizations use PhaseV's platform to rapidly design and execute adaptive, Bayesian and fixed clinical trials, analyze data to uncover heterogeneous treatment effects, stratify patients and inform future R&D and portfolio decisions. 

PhaseV says its platform has reduced trial costs by 50%, decreased enrollment size and trial duration by 40%, and increased the probability of trial success by over 30%. To date, the company has delivered results for more than 30 leading pharma/biotech sponsors and CROs spanning multiple therapeutic areas, including neurology, oncology, immunology, GI and rare diseases, the company said.

"The pharma industry is at a critical crossroads, as traditional approaches to designing and executing clinical trials struggle to meet growing demands for speed, cost-efficiency, and higher success rates," said Raviv Pryluk, Ph.D., CEO and co-founder of PhaseV, in a statement. "This funding fuels our mission to support more pharma, biotech, and CROs in embracing AI and machine learning to unlock the next era of clinical development. Our solutions deliver clear ROI by increasing trial success rates, reducing costs, and accelerating time to market."

The funding will allow PhaseV to grow its vertical AI platform to provide holistic solutions for clinical development. 


Bessemer Venture Partners backs DataHub's $35M series B round

DataHub, an open-source metadata platform, pocketed $35 million in series B funding led 

Bessemer Venture Partners led the round, with participation from 8VC, Tru Arrow, SineWave, In-Q-Tel and Zero Prime. 

Healthcare and tech organizations are facing challenges in accessing their data and artificial intelligence information. Companies struggle with "missing context" that prevents both humans and machines from effectively working with data, according to DataHub. The company provides a real-time metadata platform that brings order to data and AI chaos, enabling AI to interact with an organization's data assets to provide complete context. 

The company has raised $65 million to date.

The company's context management platform provides discovery, observability and control across data, AI models and AI agents. 

"With the shift toward business-critical AI and customer-facing predictive applications, enterprises need robust metadata management to ensure AI systems can reliably work with data," said Shirshanka Das, chief technology officer and co-founder of DataHub, in a statement. "DataHub provides the context that AI systems need to understand data lineage, quality, and semantics—enabling organizations to unlock the full potential of their AI investments."

DataHub's open source offering is being used by more than 3,000 organizations globally including Apple, Chime, Foursquare, Netflix, Optum, Pinterest and Slack. The company has experienced 6x growth in selling the enterprise managed service, DataHub Cloud, over the last two years.

The company will use the new capital to invest in the DataHub open source community, which has grown to over 13,000 members, accelerate R&D with focus on AI governance and context management capabilities, scale go-to-market operations to meet growing enterprise demand and build enterprise-grade customer success capabilities.


Behavioral health software provider Dazos banks $25M

Dazos, which developed a customer relationship management platform for behavioral health providers, raised $25 million in series A funding from New York-based Radian Capital. 

The company says its technology is custom-built for behavioral health users and workflows and gives teams the visibility and structure they need to grow efficiently, without the upfront and ongoing expenses typically associated with highly customized software implementations.

Dazos will use the funds to accelerate product development and deepen support for its growing customer base.

"This funding allows us to move faster on the things that matter most to our customers: expanding capabilities, reducing administrative burden, and providing high-quality care for more people," said David Farache, CEO of Dazos,, in a statement. "We're building a system of record for behavioral health providers that seamlessly integrates with essential clinical systems such as industry-leading EMRs, and we're just getting started."


Outcomes4Me pockets $21M for cancer care digital solution

Outcomes4Me, a patient engagement platform for cancer patients, secured $21 million in fresh funding.

Salica Investments backed the round, with participation from all existing investors: Labcorp Venture Fund, Forecast Labs, Northpond Ventures, Sierra Ventures, Asset Management Ventures, IRA Capital, and Merstal LTD. Outcomes4Me has raised $38 million to date.

The company provides a digital solution for cancer care, and uses AI and machine learning to help cancer patients navigate their care and access personalized treatment information. Outcomes4Me’s AI-driven platform integrates real-time clinical guidelines, genomic insights, medication and symptom tracking, clinical trial matching, and patient peer communities into a single, easy-to-use interface for patients with cancer, according to the company.

Outcomes4Me says it's taking strategic moves toward expanding internationally. The company will use the fresh funding to accelerate its market penetration across a broader range of cancer types, geographies, and global markets, leverage its proprietary datasets and expand its AI capabilities to drive even more precise, real-time personalized treatment recommendations and scale its collaborations with health systems and life sciences companies globally

The company also aims to scale its revenue streams through new partnerships, international expansion and innovative business models


AssistIQ secures $11.5M to improve hospital supply chain with AI

AssistIQ is an artificial intelligence company using computer vision to enhance how hospitals manage surgical and procedural supply chains.

The company picked up $11.5 million in a series A funding round led by Battery Ventures with participation from return investor Tamarind Hill. 

The company uses computer vision, AI and machine learning to improve the way supplies and implants are managed in the operating room and procedural areas. The technology captures every item used in operating and procedural rooms, helping hospitals recover revenue, streamline clinical operations and boost staff satisfaction, according to the company.

AssistIQ will use the funding to expand its flagship product, AIQ Capture, to more health systems and hospitals.

U.S. medical and surgical supply expenses have increased by an average of 6.5% annually since 2017, reaching $57 billion in 2023, according to data from Definitive Healthcare. Contributing to these rising costs are factors such as unnecessary variability in the use of similar products and the waste of unused surgical items. 

AssistIQ provides hospitals real-time, automated visibility into what’s actually used for surgeries and other high-cost procedures. The company's AI-based platform replaces outdated barcode scans and paper logs with computer vision. The technology is designed  to drive down surgical costs by automating supply capture and surfacing data and insights.

Northwell Health, New York State’s largest healthcare provider, is rolling out AssistIQ across all operating rooms at North Shore University Hospital and the Dorothy & Alvin Schwartz Ambulatory Surgery Center in Manhasset, N.Y. Northwell also works with the company as a design partner, playing a key role in shaping the clinical and supply chain integration of AIQ Capture.

Earlier this year, Owensboro Health Regional Hospital in Owensboro, Ky., became the first U.S. hospital to integrate AIQ Capture with Epic. AssistIQ has several additional health system Epic integrations planned in the coming months.


Axle Health pockets $10M to scale at-home healthcare logistics tech

Axle Health developed technology for home healthcare operations and plans to power up its artificial intelligence capabilities, including AI-powered scheduling and routing algorithms and generative AI patient engagement solutions.

The startup banked $10 million in series A financing round to scale its proprietary at-home healthcare logistics platform. F-Prime led the investment, with participation from Y Combinator, Pear VC and Lightbank.

Healthcare continues to shift toward home-based care, but many organizations lack the necessary logistics backbone to power these operations.

Adam Stansell, who helped launch Uber Eats and worked at Motive, a fleet management software company, teamed up with Connor Hailey and some former Uber colleagues to start Axle Health with the aim of bringing their logistics expertise to the healthcare industry, according to Aim Research.

The company says its platform solves the critical operational challenges that have historically limited the scale and efficiency of home healthcare. The company's EMR integrated software solution enables healthcare organizations to seamlessly deploy clinicians for in-home visits through smart scheduling, route optimization and automated patient engagement. This technology-first approach has led to increases of up to 30% in overall clinician productivity, according to the company.

Axle Health's healthcare logistics engine processes millions of data points, including traffic patterns, provider credentials, patient needs and geographic constraints, to optimize routing in real time and predict potential bottlenecks before they occur, executives said.

"The healthcare industry is experiencing a fundamental shift toward home-based care, accelerated by changing patient preferences, value-based care initiatives, and advances in remote monitoring technologies," Stansell said in a statement. "With this investment, we're positioned to meet the explosive demand for home healthcare by giving providers the technological infrastructure they need to scale operations efficiently. Our mission is to make high-quality home healthcare accessible to everyone who needs it, regardless of location or socioeconomic status."

The company will use the latest investment to fuel its expansion plans, including scaling its proprietary healthcare logistics platform and growing its engineering and operations teams.